alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2

 

I, Brian P. Alessi, certify that:

 

| 1.  I have reviewed this Form 10-Q of Emerging Vision, Inc.; |
|--------------------------------------------------------------|

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

 

 (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 (b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; 

 

 (c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; 

 

5.  The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; 

 

 (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

| Date:       August 14, 2006 |   |
|-----------------------------|--------|

 

 

 

| /s/ Brian P. Alessi     |
|-------------------------|
| Brian P. Alessi         |
| Chief Financial Officer |
Exhibit 32.1
 PHOTON DYNAMICS, INC.
CERTIFICATIONS PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
  /s/ Jeffrey A. Hawthorne

Jeffrey A. Hawthorne
    
    
    
    /s/ James P. Moniz

James P. MonizPresident and Chief Executive Officer
    
    
    
    Chief Financial Officer
An official website of the United States government         Here's how you know         
**Official websites use .mil**
A **.mil** website belongs to an official U.S. Department of Defense organization in the United States.
**Secure .mil websites use HTTPS**
 A **lock (lock )** or **https://** means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content (Press Enter).

U.S. Indo-Pacific CommandUSINDOPACOM

U.S. Indo-Pacific Command

Search

Search
Search

-  Home		 
-  Leadership    -  Commander         
  -  Deputy Commander         
  -  Chief of Staff         
  -  Senior Enlisted Leader 
-  About USINDOPACOM    -  History         
  -  USPACOM Area of Responsibility         
  -  USPACOM Previous Commanders         
  -  Women, Peace and Security 
-  Organization    -  Organization Chart 
-  Media    -  News      -  Spotlight 
  -  Photos         
  -  Speeches / Testimony         
  -  Freedom of Information Act      -  FOIA - Reading Room         
    -  Submit FOIA Request         
    -  Request Status         
    -  FOIA FAQS 
-  Resources    -  Travel Requirements         
  -  Useful Theater Information         
  -  FAQ         
  -  Useful Links 
-  Newcomers		 
-  Contact    -  Directory         
  -  Media Inquiries         
  -  Industry Engagements 
-  JTF - Red Hill		 
-  JTF-Micronesia		 

Home : Media : News : News Article View

# Readout of Secretary of Defense Lloyd Austin III Phone Call With Indonesian Minister of Defense, Prabowo Subianto

DOD NEWS

**                    SHARE                

**                    PRINT                

More
##### 



Exhibit 32.1 CERTIFICATION OF PRESIDENT AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Edwin E. Catmull, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the
Quarterly Report of Pixar on Form 10-Q for the period ended July 3, 2004 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and that information contained in such Form 10-Q fairly
presents in all material respects the financial condition and results of
operations of Pixar. By:
    
    /s/ EDWIN E. CATMULLName:
    
    Edwin E. CatmullTitle:
    
    President
 Date: August 12, 2004 I, Simon T. Bax, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report of Pixar on Form 10-Q for the period ended July 3, 2004 fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934 and that information contained in such Form 10-Q fairly presents in all
material respects the financial condition and results of operations of Pixar. By:
    
    /s/ SIMON T. BAXName:
    
    Simon T. BaxTitle:
    
    Executive Vice President and Chief Financial Officer
 Date: August 12, 2004
Exhibit 32.2

STATEMENT PURSUANT TO 18 U.S.C. §1350

Pursuant
to 18 U.S.C. §1350, the undersigned certifies that this Quarterly Report on Form 10-Q for the period ended September 30, 2007 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the
financial condition and results of operations of Millennium Pharmaceuticals, Inc.

|Dated: November 9, 2007 | /s/ MARSHA H. FANUCCIMarsha H. Fanucci
Senior Vice President and Chief Financial Officer
(Principal financial officer)
|----------------------- | ----------------------------------------------------------------------------------------------------------------------

A
signed original of this written statement required by Section 906 has been provided to Millennium Pharmaceuticals, Inc. and will be retained by Millennium Pharmaceuticals, Inc.
and furnished to the Securities and Exchange Commission or its staff upon request.

---



QuickLinks
**Exhibit
      32.2**





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED
      PURSUANT


TO
      SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002











In
      connection with the Annual  Report of AmeriChip International, Inc.
      .(the "Company") on Form 10-KSB for
      the  year  ended  November 30, 2007,  as
      filed with the Securities and Exchange  Commission on the date hereof
      (the "Report"),  I, Thomas Schwanitz, Chief Financial Officer of the
      Company,  certify,  pursuant to 18 U.S.C. 1350, as adopted
      pursuant to Section 906 of the Sarbanes-Oxley Act of 2001, that:





The
      Report
      fully complies with the requirements of Section 13(a) or 15(d) of the Securities
      Exchange Act of 1934; and





The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





Dated:  February
      27, 2008








/s/
      Thomas
      Schwanitz





Thomas
      Schwanitz, Chief
      Financial Officer
PAUL BRANCH,

Petitioner,

v.

STATE OF FLORIDA,

Respondent.

___________________________/

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D16-4976

Opinion filed December 9, 2016.

Petition Alleging Ineffective Assistance of Appellate Counsel -- Original 

Jurisdiction.

Paul Branch, pro se, Petitioner.

Pamela Jo Bondi, Attorney General, Tallahassee, for Respondent.

PER CURIAM.

The petition alleging ineffective assistance of appellate counsel is denied on the 

merits.

ROBERTS, C.J., ROWE and WINSOR, JJ., CONCUR.
C OURT OF A PPEALS FOR THE

F IRST D ISTRICT OF T EXAS AT H OUSTON

O RDER R EINSTATING A PPEAL

Appellate case name: Wade Harrell Thomson v. The State of Texas

Appellate case number: 01

- 20

- 00434

- CR

Trial court case number: 18072 CT I

- X

Trial court: 12th District Court of Grimes County

On September 17, 2020, this appeal was abated and remanded to the trial court to hold an evidentiary hearing and rule on appellant’s motion for new trial. A supplemental record has been

filed with our Court demonstrati ng that the hearing was held and the trial court denied the motion for new trial. Accordingly, we reinstate this appeal on the Court’s active docket and grant appellant’s motion to extend the deadline for filing his brief to April 7, 2021

.

It is so ORDERED

.

Judge’s signature:

___

/s/ Sarah B. Landau

___________________ _________________ Acting individually

Date: __ March 11, 2021

___
**Exhibit32.2**

 

INSIGNIASOLUTIONS PLC

 

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection withthe Quarterly Report of InsigniaSolutions plc (the “Company”) on Form 10-Q/A for the quarter endedMarch 31, 2004, as filed with the Securities and Exchange Commission onthe date hereof (the “Report”), I, RobertE. Collins, Chief Financial Officer of the Company, certify, pursuant to18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that:

 

(1)       The Report fully complies with the requirementsof Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)       The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.

 

 
|  /s/  Robert  E. Collins |   |
|------------------------------------|--------|
| Robert E. Collins                  |
| Chief Financial Officer            |
| July 23, 2004                 |

 

----
<PAGE>


                                                                 Exhibit 10.3(b)


                               PHARMACOPEIA, INC.
                            1995 DIRECTOR OPTION PLAN

                                 AMENDMENT NO. 2



Pursuant to the power reserved to it in Article Three, Section II of the
Pharmacopeia, Inc. 1995 Director Option Plan, as amended (the "Plan"), the Board
of Directors of Pharmacopeia, Inc. hereby amends the Plan as follows:

                  1.       Article Two, Section I. D. is hereby amended to read
         as follows:

                       "EXERCISE OF OPTIONS. The initial option granted to an
         Eligible Director, pursuant to Article Two, Section I.A.1., shall
         become exercisable in a series of three (3) equal and successive annual
         installments over the Optionee's period of continued service as a Board
         member, with the first such installment to become exercisable upon the
         Optionee's completion of one (1) year of Board service measured from
         the option grant date. An option subsequently granted to the Eligible
         Director on the date of an Annual Stockholders Meeting, pursuant to
         Article Two, Section I.A.2., shall become exercisable upon the date of
         the next Annual Stockholders Meeting, provided the Optionee is still
         serving on the Board on such date."

                  2.       This Amendment No. 2 to the Plan shall be effective
         and shall only apply to options granted on or after the date on which
         the Amendment is approved by a majority of Pharmacopeia's stockholders
         as set forth in Article Three, Section II.

                  To record the adoption of this Amendment No. 2, Pharmacopeia
has caused its authorized officers to affix its corporation name and seal as of
this 2nd day of May, 2001.

                                        PHARMACOPEIA, INC.


                                        By:  /s/ Joseph A. Mollica
                                           -------------------------------------
                                             Joseph A. Mollica,
                                             Chairman of the Board, President
                                             and Chief Executive Officer
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1452 Introduced in House (IH)]

<DOC>

115th CONGRESS
  1st Session
                                H. R. 1452

   To amend title 5, United States Code, to prohibit any payment for 
  lodging and other travel expenses by the Federal Government for any 
 such expenses incurred at a hotel owned or operated by the President.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 9, 2017

Mr. Blumenauer introduced the following bill; which was referred to the 
              Committee on Oversight and Government Reform

_______________________________________________________________________

                                 A BILL

 
   To amend title 5, United States Code, to prohibit any payment for 
  lodging and other travel expenses by the Federal Government for any 
 such expenses incurred at a hotel owned or operated by the President.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``No Taxpayer Revenue Used to Monetize 
the Presidency Act of 2017'' or the ``No TRUMP Act of 2017''.

SEC. 2. LIMITATION ON PAYMENTS FOR LODGING AND OTHER TRAVEL EXPENSES 
              INCURRED AT A HOTEL OWNED OR OPERATED BY THE PRESIDENT.

    (a) In General.--Subchapter IV of chapter 57 of title 5, United 
States Code, is amended by adding at the end the following:
``Sec. 5762. Limitation on payments for subsistence expenses incurred 
              at a hotel owned or operated by the President
    ``(a) In General.--No amounts may be paid from the Treasury to pay 
directly or reimburse subsistence expenses under this chapter or any 
other provision of law for any amounts expended in a hotel or other 
establishment providing daily-rate accommodation that is owned or 
operated by the President or a relative of the President.
    ``(b) Relative Defined.--In this section, the term `relative' has 
the meaning given that term in section 3110(a)(3).''.
    (b) Conforming Amendment.--The table of sections for subchapter IV 
of chapter 57 of title 5, United States Code, is amended by adding at 
the end the following new item:

``5762. Limitation on payments for subsistence expenses incurred at a 
                            hotel owned or operated by the 
                            President.''.
                                 <all>
```
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, October 22, 2018.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, October 22, 2018

The Court of Appeals hereby passes the following order

A19D0106. KENNETH BRADLEY BARNES v. MELANIE CHEEK BARNES.

Upon consideration of the Application for Discretionary Appeal, it is ordered that it be 

hereby DENIED.

LC NUMBERS:

18CV0062
#### The People of the State of New York, Respondent, v Michael Humbert, Appellant.

[631 NYS2d 724]

Appeal by the defendant from a judgment of the County Court, Nassau County (Boklan, J.), rendered July 22, 1992, convicting him of robbery in the second degree, upon his plea of guilty, and imposing sentence. The appeal brings up for review the denial, after a hearing, of that branch of the defendant’s omnibus motion which was to suppress identification testimony.

Ordered that the matter is remitted to the County Court, Nassau County, to hear and report on the defendant’s motion to withdraw his plea of guilty, on which motion the defendant’s appellate counsel shall represent him, and the appeal is held in abeyance in the interim. The County Court, Nassau County, shall file its report with all convenient speed.

In response to the defendant’s application for permission to withdraw his plea of guilty, the defense counsel stressed what he had done on the defendant’s behalf and specifically *675controverted the defendant’s contention that he had pressured him into pleading guilty. Under these circumstances, the "defendant’s right to counsel was adversely affected when his attorney * * * became a witness against him”, and the court "should not have proceeded to determine the motion without first assigning the defendant new counsel” *(People v Santana,*156 AD2d 736, 737; see *also, People v Rozzell,*20 NY2d 712; *People v Wilson,*91 AD2d 1052). Accordingly, the matter is remitted for a new determination at which the defendant shall be represented by appellate counsel. At this point, we express no opinion as to the merits of the defendant’s application. Mangano, P. J., Joy, Krausman and Florio, JJ., concur.
An official website of the United States government         Here's how you know         
**Official websites use .mil**
A **.mil** website belongs to an official U.S. Department of Defense organization in the United States.
**Secure .mil websites use HTTPS**
 A **lock (lock )** or **https://** means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content (Press Enter).

U.S. Indo-Pacific CommandUSINDOPACOM

U.S. Indo-Pacific Command

Search

Search
Search

-  Home		 
-  Leadership    -  Commander         
  -  Deputy Commander         
  -  Chief of Staff         
  -  Senior Enlisted Leader 
-  About USINDOPACOM    -  History         
  -  USPACOM Area of Responsibility         
  -  USPACOM Previous Commanders         
  -  Women, Peace and Security 
-  Organization    -  Organization Chart 
-  Media    -  News      -  Spotlight 
  -  Photos         
  -  Speeches / Testimony         
  -  Freedom of Information Act      -  FOIA - Reading Room         
    -  Submit FOIA Request         
    -  Request Status         
    -  FOIA FAQS 
-  Resources    -  Travel Requirements         
  -  Useful Theater Information         
  -  FAQ         
  -  Useful Links 
-  Newcomers		 
-  Contact    -  Directory         
  -  Media Inquiries         
  -  Industry Engagements 
-  JTF - Red Hill		 
-  JTF-Micronesia		 

Home : Media : News : News Article View

PHOTO INFORMATION

** Download

** Details

** Share

# Chief of Naval Operations Travels to RIMPAC, Meets with Exercise Participants 

**                    SHARE                

**                    PRINT                

More
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 21-844V

UNPUBLISHED

PAUL LONGO,

 Petitioner,

v.

SECRETARY OF HEALTH AND 

HUMAN SERVICES,

 Respondent.

Chief Special Master Corcoran 

Filed: February 9, 2022

Special Processing Unit (SPU); 

Ruling on Entitlement; Concession;

Table Injury; Influenza (Flu) Vaccine;

Guillain-Barre Syndrome (GBS)

Leah VaSahnja Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for 

Petitioner.

Nancy Tinch, U.S. Department of Justice, Washington, DC, for Respondent.

RULING ON ENTITLEMENT1

On February 2, 2021, Paul Longo filed a petition for compensation under the 

National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the 

“Vaccine Act”). Petitioner alleges that he suffered Guillain-Barre syndrome (“GBS”) as a 

result of an influenza (“flu”) vaccine administered on September 12, 2019. Petition at 1. 

Petitioner further alleges that the vaccine was administered within the United States, that 

he has suffered from the sequela of his injury for more than six months, and that there 

has been no previous award or compensation for his vaccine0related injury. Petition at 1-

2. The case was assigned to the Special Processing Unit of the Office of Special Masters.

1 Because this unpublished Ruling contains a reasoned explanation for the action in this case, I am required 

to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act 

of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government 

Services). This means the Ruling will be available to anyone with access to the internet. In accordance 

with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, 

the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that 

the identified material fits within this definition, I will redact such material from public access. 

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease 

of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 

300aa (2012).
2

On February 7, 2022, Respondent filed his Rule 4(c) report in which he concedes

that Petitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at 

1. Specifically, Respondent conceded that Petitioner has satisfied the criteria set forth in 

the Vaccine Injury Table and the Qualifications and Aids to Interpretation. Id. at 7. 

In view of Respondent’s position and the evidence of record, I find that 

Petitioner is entitled to compensation.

IT IS SO ORDERED.

s/Brian H. Corcoran

Brian H. Corcoran

Chief Special Master